Technical Analysis for ICLR - ICON plc

Grade Last Price % Change Price Change
grade A 140.9 1.72% 2.38
ICLR closed up 1.72 percent on Friday, May 24, 2019, on 67 percent of normal volume. The stock crossed above its 200 day moving average, improving its long-term outlook by crossing above that critical trendline.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Up
See historical ICLR trend table...

Date Alert Name Type % Chg
Crossed Above 200 DMA Bullish 0.00%
MACD Bullish Signal Line Cross Bullish 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
Multiple of Ten Bullish Other 0.00%
Fell Below 200 DMA Bearish 1.72%
20 DMA Support Bullish 1.72%
Cup with Handle Other 1.72%
Bollinger Band Squeeze Range Contraction 1.72%
Narrow Range Bar Range Contraction 1.72%
NR7 Range Contraction 1.72%

Older signals for ICLR ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

ICON Public Limited Company, a contract research organization, provides outsourced development services to the pharmaceutical, biotechnology, and medical device industries primarily in Ireland, the United States, and rest of Europe. It operates through two segments, Clinical Research and Central Laboratory. The Clinical Research segment specializes in strategic development, management, and analysis of programs that support various stages of clinical development process from compound selection to Phase I to IV clinical studies. Its clinical research services include investigator recruitment, study monitoring and data collection, case report form preparation, statistical analysis, patient safety monitoring, clinical data management, interactive voice response, electronic patient reported outcomes, medical reporting, patient registries, outcomes research, and health economics. This segment's clinical research services also comprise marker access and commercialization services, strategic analysis and data operation, clinical pharmacology, bioanalysis, immunoassay development, pharmacokinetic and pharmacodynamic analysis, study protocol preparation, regulatory consulting, product development planning, strategic consulting, pricing and market access consulting, medical imaging, contract staffing, and electronic endpoint adjudication. The Central Laboratory segment offers various laboratory services, such as sample analyses, safety testing, microbiology, custom flow cytometry, electronic transmission of test results, and biomarker development. ICON Public Limited Company was founded in 1990 and is headquartered in Dublin, Ireland.
Medicine Biotechnology Health Pharmaceutical Industry Clinical Trial Medical Imaging Design Of Experiments Interactive Voice Response Clinical Research Contract Research Organizations Laboratory Services Medical Research Clinical Data Management Biomarker
Is ICLR a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 155.33
52 Week Low 118.1
Average Volume 285,294
200-Day Moving Average 139.0148
50-Day Moving Average 136.835
20-Day Moving Average 138.4765
10-Day Moving Average 138.284
Average True Range 3.3485
ADX 9.8
+DI 21.5891
-DI 15.2141
Chandelier Exit (Long, 3 ATRs ) 134.0945
Chandelier Exit (Short, 3 ATRs ) 143.9755
Upper Bollinger Band 142.7156
Lower Bollinger Band 134.2374
Percent B (%b) 0.79
BandWidth 6.122483
MACD Line 0.6834
MACD Signal Line 0.5534
MACD Histogram 0.13
Fundamentals Value
Market Cap 7.62 Billion
Num Shares 54.1 Million
EPS 4.93
Price-to-Earnings (P/E) Ratio 28.58
Price-to-Sales 3.86
Price-to-Book 6.44
PEG Ratio 1.92
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 144.53
Resistance 3 (R3) 144.39 143.05 143.93
Resistance 2 (R2) 143.05 142.12 143.12 143.72
Resistance 1 (R1) 141.97 141.55 142.51 142.11 143.52
Pivot Point 140.63 140.63 140.90 140.70 140.63
Support 1 (S1) 139.55 139.70 140.09 139.69 138.28
Support 2 (S2) 138.21 139.13 138.28 138.08
Support 3 (S3) 137.13 138.21 137.88
Support 4 (S4) 137.27